@article{ref1,
title="Prolonged exposure therapy for PTSD among spinal cord injury survivors: study protocol for a randomized controlled trial",
journal="Contemporary clinical trials communications",
year="2021",
author="Powers, Mark B. and Pogue, Jamie R. and Curcio, Nicholas E. and Patel, Sarita and Wierzchowski, Andrea and Thomas, Estrella V. and Warren, Ann Marie and Adams, Maris and Turner, Emma and Carl, Emily and Froehlich-Grobe, Katherine and Sikka, Seema and Foreman, Michael and Leonard, Kiara and Douglas, Megan and Bennett, Monica and Driver, Simon",
volume="22",
number="",
pages="100763-100763",
abstract="The National Spinal Cord Injury Statistical Center estimates 294,000 people in the US live with a spinal cord injury (SCI), with approximately 17,810 new cases each year. Although the physical outcomes associated with SCI have been widely studied, the psychological consequences of sustaining a SCI remain largely unexplored. Scant research has focused on posttraumatic stress disorder (PTSD) in this population, despite prevalence estimates suggesting that up to 60% of individuals with SCI experience PTSD post-injury, compared to only 7% of the general US population. Fortunately, prolonged exposure therapy (PE) is a well-researched and highly effective treatment for PTSD. However, no trauma focused exposure-based therapy for PTSD (e.g. PE) has not yet been tested in a SCI population. Thus, we aim to conduct the first test of an evidence-based intervention for PTSD among patients with SCI. Adults with SCI and PTSD (N = 60) will be randomly assigned to either: (1) 12-sessions of PE (2-3 sessions per week) or (2) a treatment as usual (TAU) control group who will receive the standard inpatient rehabilitation care for SCI patients. Primary outcomes will be assessed at 0, 6, 10, and 32 weeks.<p /> <p>Language: en</p>",
language="en",
issn="2451-8654",
doi="10.1016/j.conctc.2021.100763",
url="http://dx.doi.org/10.1016/j.conctc.2021.100763"
}